<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 6; Issue 5</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Sep-Oct, 2025)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Diagnostic Challenges of Beh__ampersandsignccedil;et Disease – Focus on Neurological Involvement (Neuro- Beh__ampersandsignccedil;et) A Case Report</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>11</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Karolina</FirstName>
          <LastName>Kulicka</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Lucie</FirstName>
          <LastName>Pothen</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Idil</FirstName>
          <LastName>Gunes</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Rudy</FirstName>
          <LastName>Chapusette</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Ides M.</FirstName>
          <LastName>Colin</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Beh__ampersandsignccedil;et’s disease (BD) is a rare multisystem inflammatory disorder first described in 1937 by Turkish dermatologist Hulusi Beh__ampersandsignccedil;et. It is classically defined by a triad of recurrent oral aphthous ulcers, genital ulcers, and uveitis. Multiple studies have shown that BD can affect other organs, including the skin, joints, gastrointestinal tract, central nervous system, and blood vessels, and is therefore classified as a systemic vasculitis. The highest prevalence is found along the ancient Silk Road, covering the Middle East, Mediterranean basin, and Far East. We report the case of a 23-year-old man with BD presenting with recurrent fever, cognitive decline, lower extremity vein thrombosis, uveitis, and urinary retention. Despite those signs, the diagnosis was significantly delayed due to confounding factors, including a maternal Factor II mutation and a context of cannabis use. A comprehensive medical history including targeted questions about recurrent oral and genital ulcers led to the consideration of BD. This case underscores the importance of detailed clinical history-taking-particularly regarding mucocutaneous symptoms-and highlights both the value and limitations of International Criteria for Beh__ampersandsignccedil;et’s Disease (ICBD) in complex, multisystem presentations.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Behçet,Neuro Behçet,Diagnostic Challenges,International Criteria for Behçet’s Disease (ICBD)</Keywords>
      <URLs>
        <Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=15991&amp;title=Diagnostic Challenges of Beh__ampersandsignccedil;et Disease – Focus on Neurological Involvement (Neuro- Beh__ampersandsignccedil;et) A Case Report</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Agarwal A, Rand;uuml;bsam A, Zur Bonsen L, Pichi F, Neri P, Pleyer U. A comprehensive update on retinal vasculitis: etiologies, manifestations and treatments. J Clin Med 2022; 11: 2525.&#13;
&#13;
Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS. Treatment of venous thrombosis associated with Behand;ccedil;etand;#39;s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008; 27: 201-205.&#13;
&#13;
Al-Araji A, Kidd DP. Neuro-Behand;ccedil;etand;#39;s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8: 192-204.&#13;
&#13;
Al-Araji A, Sharquie K, Al-Rawi Z. Prevalence and patterns of neurological involvement in Behand;ccedil;etand;#39;s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 2003; 74: 608-613.&#13;
&#13;
Alpsoy E, Leccese P, Emmi G, Ohno S. Treatment of Behand;ccedil;etand;#39;s disease: an algorithmic multidisciplinary approach. Front Med 2021; 8: 624795.&#13;
&#13;
Ashjazadeh N, Borhani Haghighi A, Samangooie S, Moosavi H. Neuro-Behand;ccedil;etand;#39;s disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behand;ccedil;etand;#39;s disease in 96 Iranian patients. Exp Mol Pathol 2003; 74: 17-22.&#13;
&#13;
Banerjee S, Hamzoui K, Safari A, Borhani-Haghighi A. The cerebrospinal fluid presentations of Neuro-Behand;ccedil;et disease, a way to know the etiopathogenesis and improve armamentarium. Iran J Immunol 2021; 18: 170-178.&#13;
&#13;
Borhani-Haghighi A, Kardeh B, Banerjee S, Yadollahikhales G, Safari A, Sahraian MA, Shapiro L. Neuro-Behcetand;#39;s disease: an update on diagnosis, differential diagnoses, and treatment. Mult Scler Relat Disord 2020; 39: 101906.&#13;
&#13;
Chadli S, Khibri H, Firdaous SF, Moatassim N, Ammouri W, Maamar M, Harmouche H, Adnaoui M, Tazi Mezalek Z. Pulmonary artery aneurysms in Behand;ccedil;etand;#39;s syndrome: a case series of 51 patients. Rheumatology 2023; 62(Suppl 2): kead104.246.&#13;
&#13;
Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Behand;ccedil;etand;#39;s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014; 28: 338-347.&#13;
&#13;
Demirtand;uuml;rk O, Tand;uuml;nel H, Alemdaroglu U. Vascular manifestations of Behand;ccedil;et’s disease. In: Behand;ccedil;et’s Disease. IntechOpen; 2017: 149-189.&#13;
&#13;
Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D. Vascular Behand;ccedil;etand;#39;s syndrome: an update. Intern Emerg Med 2019; 14: 645-652.&#13;
&#13;
Giannessi C, Smorchkova O, Cozzi D, Zantonelli G, Bertelli E, Moroni C, Cavigli E, Miele V. Behand;ccedil;etand;#39;s disease: a radiological review of vascular and parenchymal pulmonary involvement. Diagnostics 2022; 12: 2868.&#13;
&#13;
Kiafar M, Faezi ST, Kasaeian A, Baghdadi A, Kakaei S, Mousavi SA, Nejadhosseinian M, Shahram F, Ghodsi SZ, Shams H, Davatchi F. Diagnosis of Behand;ccedil;etand;#39;s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol 2021; 5: 2.&#13;
&#13;
Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behand;ccedil;etand;#39;s disease: an international collaborative study. Br J Ophthalmol 2007; 91: 1579-1582.&#13;
&#13;
Mattioli I, Bettiol A, Saruhan-Direskeneli G, Direskeneli H, Emmi G. Pathogenesis of Behand;ccedil;etand;#39;s syndrome: genetic, environmental and immunological factors. Front Med 2021; 8: 713052.&#13;
&#13;
Ozguler Y, Hatemi G, Cetinkaya F, Tascilar K, Hamuryudan V, Ugurlu S, Seyahi E, Yazici H, Melikoglu M. Clinical course of acute deep vein thrombosis of the legs in Behand;ccedil;etand;#39;s syndrome. Rheumatology 2020; 59: 799-806.&#13;
&#13;
Serdaroglu P, Yazici H, Ozdemir C, Yurdakul S, Bahar S, Aktin E. Neurologic involvement in Behand;ccedil;etand;#39;s syndrome: a prospective study. Arch Neurol 1989; 46: 265-269.&#13;
&#13;
Seyahi E, Karaaslan H, Ugurlu S, Yazici H. Fever in Behand;ccedil;etand;#39;s syndrome. Clin Exp Rheumatol 2013; 31: 64-67.&#13;
&#13;
Seyahi E, Yurdakul S. Behand;ccedil;etand;#39;s syndrome and thrombosis. Mediterr J Hematol Infect Dis 2011; 3: e2011026.&#13;
&#13;
Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behand;ccedil;et disease: an analysis of 880 patients. Am J Ophthalmol 2004; 138: 373-380.&#13;
&#13;
Zhan H, Cheng L, Li Y. Neuro-Behand;ccedil;etand;#39;s disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis. Clin Exp Immunol 2025; 219: uxae123.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>